|
|
| |
 |
Evaluation of a plasmid DNA-based vaccine in rabbits, nonhuman primates, and healthy adults
From Aug Hum Vaccine, published online May 29
|
|
|
Vaccines for preventing anthrax
From Cochrane Database Syst Rev, published online Apr 15
|
|
|
Human anthrax in Turkey from 1990 to 2007
From Apr Vector-Borne Zoonotic Dis
|
|
|
Anthrax: Current, comprehensive information on pathogenesis, microbiology, epidemiology, diagnosis, treatment, and prophylaxis
CIDRAP-authored overview, updated Mar 21
|
|
|
Efficacy of recombinant anthrax vaccine against Bacillus anthracis aerosol spore challenge: preclinical evaluation in rabbits and rhesus monkeys
From Biotechnol J, published online Mar 18
|
|
|
Antimicrobial effects of interferon-inducible CXC chemokines against Bacillus anthracis spores and bacilli
|
|
|
A single-dose combination therapy that both prevents and treats anthrax infection
|
|
|
Efficient neutralization of antibody-resistant forms of anthrax toxin by a soluble receptor decoy inhibitor
From Mar Antimicrob Agents Chemother
|
|
|
Cutaneous anthrax, West Bengal, India, 2007
Letter from Emerg Infect Dis, published online Feb 21
|
|
|
Antitoxin antibodies in prophylaxis and treatment of inhalation anthrax
From Feb Future Microbiol
|
|
|
A case of pneumonia caused by Bacillus anthracis secondary to gastrointestinal anthrax
From Int J Infect Dis, published online Feb 9
|
|
|
Bioterrorism for the respiratory physician
|
|
|
Role of visible light-activated photocatalyst on the reduction of anthrax spore-induced mortality in mice
From PLoS ONE, published online Jan 9
|
|
|
Detection of anthrax toxin by an ultrasensitive immunoassay using europium nanoparticles
From Clin Vaccine Immunol, published online Jan 7
|
|
|
Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007
|
|
|
Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax
From Infect Immun, published online Dec 29
|
|
|
A short course of antibiotic treatment is effective in preventing death from experimental inhalational anthrax after discontinuing antibiotics
From J Infect Dis, published online Dec 19
|
|
|
Mucosal immunization with attenuated Salmonella enterica serovar Typhi expressing protective antigen of anthrax toxin (PA83) primes monkeys for accelerated serum antibody responses to parenteral PA83 vaccine
From J Infect Dis, published online Dec 19
|
|
|
Investigations and control measures following a case of inhalation anthrax in East London in a drum maker and drummer, October 2008
|
|
|
Identification of a surrogate marker for infection in the African green monkey model of inhalation anthrax
|
|
|
Is 60 days of ciprofloxacin administration necessary for postexposure prophylaxis for Bacillus anthracis?
From Nov Antimicrob Agents Chemother
|
|
|
Amoxicillin for postexposure inhalational anthrax in pediatrics: rationale for dosing recommendations
From Pediatr Infect Dis, published online Oct 1
|
|
|
Why do UK military personnel refuse the anthrax vaccination?
From Biosecur Bioterr, published online Sep 17
|
|
